Triple-Negative Breast Cancer Research and Education Act of 2017

Summary

Triple-Negative Breast Cancer Research and Education Act of 2017 This bill requires the National Institutes of Health to expand, intensify, and coordinate programs for research on triple-negative breast cancer (the cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein). The Centers for Disease Control and Prevention must develop and disseminate to the public information regarding triple-negative breast cancer, including information on: (1) the incidence and prevalence of triple-negative breast cancer among women, (2) the elevated risk for minority women, and (3) the availability of a range of treatment options. The Health Resources and Services Administration must develop and disseminate information on triple-negative breast cancer to health care providers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 6 April 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 6 April 2017

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 6 April 2017

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.